Inventor
Hao Chen
Inventor
Columbia, MD, US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07KPeptides15%
C07DHeterocyclic compounds10%
C12NMicroorganisms or enzymes4%
Y02ATechnologies for adaptation to climate change4%
A01NPreservation of bodies of humans or animals or plants or parts thereof2%
A61BDiagnosis2%
A61LMethods or apparatus for sterilising materials or objects in general2%
A61MDevices for introducing media into, or onto, the body2%
PatentTitleYear
11,051,402Fluorine-containing substrate, copper clad laminate, and printed circuit board202110,898,617Medical products and methods configured for controlled release of nitric oxide202110,786,507Pharmaceutical composition containing JAK kinase inhibitor or pharmaceutically acceptable salt thereof202010,654,851Deuterated 3-(4,5-substituted aminopyrimidine)phenyl derivatives and use thereof202010,258,584Pregabalin sustained-release preparation201910,124,111Small molecule dye for molecular imaging and photothermal therapy20189,879,056'Insecticidal protein'20189,604,945'Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders'20179,149,466'Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions'20159,119,843'Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions'20158,691,853'Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions'20148,415,385'Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders'20137,265,263'Potato transcription factors, methods of use thereof, and a method for enhancing tuber development'20075,532,214'Anti-HIV protein, TAP 29, from tricosanthes, DNA coding therefor and therapeutic uses thereof'19965,484,889'Plant protein useful for treating tumors and HIV infection'19965,317,009'Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof'19945,221,732'Antimicrobial magainin modified peptides'19934,468,383'Dimeric enkephalins'1984Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1984–1996Patents assigned to US HEALTH (4)· patent assignee history
1993–1996Based in Potomac, MD, US· patent location history
1994–1996Patents assigned to AMERICAN BIOSCIENCES (3)· patent assignee history
2013–2015Patents assigned to CHEN HAO (3)· patent assignee history
2013–2015Patents assigned to LIU MING (3)· patent assignee history
2013–2017Based in Columbia, MD, US· patent location history
2014–2017Patents assigned to CALIPER LIFE SCIENCES INC (4)· patent assignee history
2019–2020Based in Jiangsu, CN· patent location history
2021Based in Taipei, TW· patent location history
2021Based in Ann Arbor, MI, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CALIPER LIFE SCIENCES INC | 4 | 2014–2017 |
| US HEALTH | 4 | 1984–1996 |
| AMERICAN BIOSCIENCES | 3 | 1994–1996 |
| CHEN HAOself | 3 | 2013–2015 |
| LIU MING | 3 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Columbia, Maryland, US | 5 | 2013–2017 |
| Potomac, Maryland, US | 4 | 1993–1996 |
| Jiangsu, CN | 2 | 2019–2020 |
| Taipei, TW | 1 | 2021 |
| Ann Arbor, MI, US | 1 | 2021 |